$149.98
0.83% day before yesterday
NYSE, Sep 06, 10:10 pm CET
ISIN
US23918K1088
Symbol
DVA

DaVita HealthCare Partners Stock price

$149.98
+12.99 9.48% 1M
+18.00 13.64% 6M
+45.22 43.17% YTD
+51.09 51.66% 1Y
+17.81 13.48% 3Y
+90.61 152.62% 5Y
+75.55 101.50% 10Y
NYSE, Closing price Fri, Sep 06 2024
+1.24 0.83%
ISIN
US23918K1088
Symbol
DVA
Sector

Key metrics

Market capitalization $12.58b
Enterprise Value $25.53b
P/E (TTM) P/E ratio 15.96
EV/FCF (TTM) EV/FCF 19.97
EV/Sales (TTM) EV/Sales 2.04
P/S ratio (TTM) P/S ratio 1.00
P/B ratio (TTM) P/B ratio 21.29
Revenue growth (TTM) Revenue growth 6.69%
Revenue (TTM) Revenue $12.52b
EBIT (operating result TTM) EBIT $1.84b
Free Cash Flow (TTM) Free Cash Flow $1.28b
Cash position $523.94m
EPS (TTM) EPS $9.40
P/E forward 15.01
P/S forward 0.99
EV/Sales forward 2.00
Short interest 10.77%
Show more

Is DaVita HealthCare Partners a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

DaVita HealthCare Partners Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a DaVita HealthCare Partners forecast:

1x Buy
10%
7x Hold
70%
2x Sell
20%

Analyst Opinions

10 Analysts have issued a DaVita HealthCare Partners forecast:

Buy
10%
Hold
70%
Sell
20%

Financial data from DaVita HealthCare Partners

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
12,524 12,524
7% 7%
100%
- Direct Costs 9,173 9,173
1% 1%
73%
3,351 3,351
24% 24%
27%
- Selling and Administrative Expenses 762 762
10% 10%
6%
- Research and Development Expense - -
-
-
2,589 2,589
29% 29%
21%
- Depreciation and Amortization 746 746
1% 1%
6%
EBIT (Operating Income) EBIT 1,842 1,842
46% 46%
15%
Net Profit 860 860
89% 89%
7%

In millions USD.

Don't miss a Thing! We will send you all news about DaVita HealthCare Partners directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DaVita HealthCare Partners Stock News

Negative
Forbes
9 days ago
If you are a Johnson & Johnson investor and have been enjoying the stock's steady dividends, it may be time to look elsewhere. As of this moment, we find DaVita - a healthcare company focused on kidney dialysis services - and Duke Energy - an electric and natural gas utility company based in North Carolina - as more attractive buys than Johnson & Johnson.
Positive
Finbold
13 days ago
Warren Buffett, the famed ‘ Oracle of Omaha ,' allegedly made his first stock pick at age 11, all the way back in the early 1940s. In the following 80-odd years, he first became a millionaire, then a billionaire, and has perfected the art of getting rich slowly.
Positive
Seeking Alpha
18 days ago
DVA stock is up 65% since my last publication, and recent updates show a positive fundamental economics and growth outlook. Q2 earnings exceeded expectations, management forecasts strong growth in operating income and earnings. Embedded expectations are low to see the business trade at $200/share at a 1.9x EV/IC multiple, underlined by cash earnings.
More DaVita HealthCare Partners News

Company Profile

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Head office United States
CEO Javier Rodriguez
Employees 70,000
Founded 1994
Website www.davita.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today